| 產(chǎn)品名稱 |
Human Coxsackievirus A 5 |
| 商品貨號(hào) |
B163367 |
| Classification |
Picornaviridae, Enterovirus, Human enterovirus A |
| Deposited As |
Coxsackievirus A5 |
| Agent |
Human Coxsackievirus A 5 |
| Strain |
Swartz |
| Applications |
Produces degeneration of muscle fibers including loss of striation and hyaline changes. Produces degeneration of muscle fibers including loss of striation and hyaline changes. |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Isolation |
feces of patient with poliomyelitis, New York State, 1950 |
| Product Format |
frozen |
| Storage Conditions |
;-60°C |
| Comments |
Produces degeneration of muscle fibers including loss of striation and hyaline changes. Produces degeneration of muscle fibers including loss of striation and hyaline changes. |
| Effect on Host |
Yes, in vivo effects: Flaccid paralysis Flaccid paralysis |
| Name of Depositor |
NIH/NIAID |
| Source |
feces of patient with poliomyelitis, New York State, 1950 |
| Year of Origin |
1950 |
| References |
Diagnostic Proc. for Virus and Rickettsial Diseases, 2nd ed.. New York: Am. Public Health Assoc; 1956.
|
